{"id":"https://openalex.org/W1964589757","doi":"https://doi.org/10.1097/00006231-200208000-00005","title":"Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67","display_name":"Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67","publication_year":2002,"publication_date":"2002-08-01","ids":{"openalex":"https://openalex.org/W1964589757","doi":"https://doi.org/10.1097/00006231-200208000-00005","mag":"1964589757","pmid":"https://pubmed.ncbi.nlm.nih.gov/12124477"},"language":"en","primary_location":{"id":"doi:10.1097/00006231-200208000-00005","doi":"https://doi.org/10.1097/00006231-200208000-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00006231-200208000-00005","pdf_url":null,"source":{"id":"https://openalex.org/S108023290","display_name":"Nuclear Medicine Communications","issn_l":"0143-3636","issn":["0143-3636","1473-5628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nuclear Medicine Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038658179","display_name":"Tarik Belhocine","orcid":"https://orcid.org/0000-0002-3234-9480","observed_orcids":["https://orcid.org/0000-0002-3234-9480"]},"institutions":[{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"T. BELHOCINE","raw_affiliation_strings":["Division of Nuclear Medicine, Centre Hospitalier Universitaire, Sart Tilman, B35 4000 Li\u00e8ge 1, Belgium","Nuclear Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nuclear Medicine, Centre Hospitalier Universitaire, Sart Tilman, B35 4000 Li\u00e8ge 1, Belgium","institution_ids":["https://openalex.org/I4210134544"]},{"raw_affiliation_string":"Nuclear Medicine and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108462860","display_name":"J.B. Foidart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. FOIDART","raw_affiliation_strings":["Nuclear Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111030237","display_name":"P. Rigo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. RIGO","raw_affiliation_strings":["Nuclear Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074921963","display_name":"Fadi Najjar","orcid":"https://orcid.org/0000-0002-6169-1576","observed_orcids":["https://orcid.org/0000-0002-6169-1576"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. NAJJAR","raw_affiliation_strings":["Nuclear Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111745686","display_name":"A Thiry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"A. THIRY","raw_affiliation_strings":["Pathology, Centre Hospitalier Universitaire, Sart Tilman, B35, 4000 Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Centre Hospitalier Universitaire, Sart Tilman, B35, 4000 Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I4210134544"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058132033","display_name":"Pascale Quatresooz","orcid":"https://orcid.org/0000-0002-0140-9655","observed_orcids":["https://orcid.org/0000-0002-0140-9655"]},"institutions":[{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P. QUATRESOOZ","raw_affiliation_strings":["Pathology, Centre Hospitalier Universitaire, Sart Tilman, B35, 4000 Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Centre Hospitalier Universitaire, Sart Tilman, B35, 4000 Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I4210134544"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108228826","display_name":"R. Hustinx","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. HUSTINX","raw_affiliation_strings":["Nuclear Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0447,"has_fulltext":false,"cited_by_count":130,"citation_normalized_percentile":{"value":0.90869062,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"23","issue":"8","first_page":"727","last_page":"734"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carcinoid-tumor","display_name":"carcinoid tumor","score":0.9929999709129333},{"id":"https://openalex.org/keywords/fdg-pet","display_name":"FDG-PET","score":0.9290000200271606},{"id":"https://openalex.org/keywords/somatostatin-receptor-scintigraphy","display_name":"somatostatin receptor scintigraphy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-staging","display_name":"tumor staging","score":0.8519999980926514},{"id":"https://openalex.org/keywords/metastasis-detection","display_name":"metastasis detection","score":0.6309999823570251},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.7279999852180481},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.9990000128746033},{"id":"https://openalex.org/keywords/diagnostic-accuracy","display_name":"diagnostic accuracy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/typical-carcinoid","display_name":"typical carcinoid","score":0.6010000109672546},{"id":"https://openalex.org/keywords/histopathological-correlation","display_name":"histopathological correlation","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.7895607948303223},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.7604970932006836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7411401271820068},{"id":"https://openalex.org/C2779902710","wikidata":"https://www.wikidata.org/wiki/Q1130465","display_name":"Scintigraphy","level":2,"score":0.5791442394256592},{"id":"https://openalex.org/C207886595","wikidata":"https://www.wikidata.org/wiki/Q1456138","display_name":"Pathological","level":2,"score":0.5539090037345886},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.5475521683692932},{"id":"https://openalex.org/C2777415128","wikidata":"https://www.wikidata.org/wiki/Q419849","display_name":"Fluorodeoxyglucose","level":3,"score":0.5269017219543457},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4517570734024048},{"id":"https://openalex.org/C2908862229","wikidata":"https://www.wikidata.org/wiki/Q1734755","display_name":"Carcinoid tumour","level":2,"score":0.4496486783027649},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.426454097032547},{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.36904746294021606},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22622141242027283}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002276","descriptor_name":"Carcinoid Tumor","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D002276","descriptor_name":"Carcinoid Tumor","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D002276","descriptor_name":"Carcinoid Tumor","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002276","descriptor_name":"Carcinoid Tumor","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D004369","descriptor_name":"Pentetic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005188","descriptor_name":"False Negative Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013223","descriptor_name":"Statistics as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019394","descriptor_name":"Ki-67 Antigen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D019788","descriptor_name":"Fluorodeoxyglucose F18","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/00006231-200208000-00005","doi":"https://doi.org/10.1097/00006231-200208000-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00006231-200208000-00005","pdf_url":null,"source":{"id":"https://openalex.org/S108023290","display_name":"Nuclear Medicine Communications","issn_l":"0143-3636","issn":["0143-3636","1473-5628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nuclear Medicine Communications","raw_type":"journal-article"},{"id":"pmid:12124477","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12124477","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nuclear medicine communications","raw_type":"Comparative Study"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/18857","doi":null,"is_oa":false,"landing_page_url":"https://orbi.uliege.be/handle/2268/18857","pdf_url":null,"source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nuclear Medicine Communications, 23 (8), 727-734 (2002-08)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1864670886","https://openalex.org/W1928540068","https://openalex.org/W1969294453","https://openalex.org/W1982904756","https://openalex.org/W2004542526","https://openalex.org/W2014086933","https://openalex.org/W2017428584","https://openalex.org/W2059406656","https://openalex.org/W2062196347","https://openalex.org/W2062809548","https://openalex.org/W2063694297","https://openalex.org/W2065361341","https://openalex.org/W2072327797","https://openalex.org/W2072451938","https://openalex.org/W2085026484","https://openalex.org/W2103940412","https://openalex.org/W2170827983","https://openalex.org/W2172054532","https://openalex.org/W2172205800","https://openalex.org/W2243041971","https://openalex.org/W2257907694","https://openalex.org/W2331691891","https://openalex.org/W2434131261","https://openalex.org/W4233636985","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2508139986","https://openalex.org/W2075812365","https://openalex.org/W2589046941","https://openalex.org/W2341708390","https://openalex.org/W2082228940","https://openalex.org/W2045852597","https://openalex.org/W4229018195","https://openalex.org/W4210340180","https://openalex.org/W4387381597","https://openalex.org/W2013346504"],"abstract_inverted_index":{"We":[0,133],"performed":[1,55],"this":[2],"study":[3],"in":[4,56,61],"order":[5],"to":[6,41,105,158],"evaluate":[7],"the":[8,32,35,46,50,89,126,130,138],"diagnostic":[9],"accuracy":[10],"of":[11,34,49,88,140,149],"whole-body":[12],"fluorodeoxyglucose":[13],"positron":[14],"emission":[15],"tomography":[16],"(FDG":[17],"PET)":[18],"imaging":[19],"and":[20,30,59,80,99,107,129],"somatostatin":[21],"receptor":[22],"scintigraphy":[23],"(SRS)":[24],"for":[25,110,142],"localizing":[26],"primary":[27,97],"carcinoid":[28,146],"tumours":[29,98,113],"evaluating":[31,143],"extent":[33],"disease.":[36],"A":[37],"secondary":[38],"aim":[39],"was":[40,54,123],"correlate":[42],"those":[43],"findings":[44],"with":[45,117,145,160],"histological":[47,127],"characteristics":[48],"lesions.":[51],"FDG":[52,92,153],"PET":[53,93,154],"17":[57],"patients":[58,64,144,159],"SRS":[60,136],"16.":[62],"All":[63,69],"had":[65],"pathologically":[66],"proven":[67],"carcinoids.":[68],"lesions":[70],"were":[71,83,114],"verified":[72],"by":[73,77],"histopathological":[74],"analysis":[75],"or":[76],"follow-up.":[78],"Ki-67":[79,119],"p53":[81],"expression":[82],"assessed":[84],"as":[85,103],"an":[86],"indicator":[87],"tumours'":[90],"aggressiveness.":[91],"correctly":[94],"identified":[95],"4/7":[96],"8/11":[100],"metastatic":[101],"spreads,":[102],"compared":[104],"six":[106],"10":[108],"respectively,":[109],"SRS.":[111,164],"Most":[112],"typical":[115],"carcinoids":[116],"low":[118],"expression.":[120],"No":[121],"correlation":[122],"found":[124],"between":[125],"features":[128],"tracer's":[131],"uptake.":[132],"conclude":[134],"that":[135],"remains":[137],"modality":[139],"choice":[141],"tumours,":[147],"regardless":[148],"their":[150],"proliferative":[151],"activity.":[152],"should":[155],"be":[156],"reserved":[157],"negative":[161],"results":[162],"on":[163]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}